Odyssey Health (ODYY) Income towards Parent Company (2014 - 2026)
Odyssey Health (ODYY) posted Income towards Parent Company of -$825105.0 for Q2 2026, down 38.82% on a QoQ basis from -$594371.0 in Q1 2026, and down 333.24% year-over-year from $353758.4 in Q2 2025.
Analysis
Odyssey Health (ODYY) Income towards Parent Company (2014 - 2026) Analysis & Trends
Odyssey Health has reported Income towards Parent Company for 13 years, with the latest figure at -$825105.0 in Q2 2026.
- On a quarterly basis, Income towards Parent Company fell 333.24% year-over-year to -$825105.0 in Q2 2026; TTM through Apr 2026 was -$2.0 million, a 124.59% decrease from a year earlier, with the FY2025 full-year figure at -$1.3 million, up 52.1% from the prior year.
- Income towards Parent Company was -$825105.0 for Q2 2026 at Odyssey Health, down from -$594371.0 in the prior quarter.
- The five-year high for Income towards Parent Company was $153644.0 in Q3 2024, with the low at -$3.1 million in Q2 2022.
- Average Income towards Parent Company over 5 years is -$1.0 million, with a median of -$731246.0 recorded in 2023.
- The sharpest annual moves came in 2024 and 2026: Income towards Parent Company jumped 118.87% in 2024, then tumbled 333.24% in 2026.
- Over 5 years, Income towards Parent Company stood at -$2.1 million in 2022, then jumped by 74.96% to -$538100.0 in 2023, then dropped by 20.46% to -$648208.0 in 2024, then jumped by 38.52% to -$398526.0 in 2025, then tumbled by 107.04% to -$825105.0 in 2026.
- The last three Income towards Parent Company figures came in at -$825105.0 (Q2 2026), -$594371.0 (Q1 2026), and -$398526.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 178.50 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.21 Bn | 118.99 Bn | 1.96 Bn |
| 3 | Medtronic | 118.33 Bn | 109.51 Bn | 6.34 Bn |
| 4 | Stryker | 104.21 Bn | 100.73 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.39 Bn | 65.86 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.69 Bn | 45.43 Bn | 1.35 Bn |
| 7 | Alcon | 33.94 Bn | 32.48 Bn | 1.68 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 21.15 Bn | 20.67 Bn | 684.20 Mn |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -825,105.00 |
| Jan 31, 2026 | -594,371.00 |
| Oct 31, 2025 | -398,526.00 |
| Jul 31, 2025 | -214,583.00 |
| Apr 30, 2025 | -190,450.00 |
| Jan 31, 2025 | -220,024.00 |
| Oct 31, 2024 | -648,208.00 |
| Jul 31, 2024 | 153,644.00 |
| Apr 30, 2024 | -474,598.00 |
| Jan 31, 2024 | -1.30 Mn |
| Oct 31, 2023 | -538,100.00 |
| Jul 31, 2023 | -814,284.00 |
| Apr 30, 2023 | -1.28 Mn |
| Jan 31, 2023 | -1.68 Mn |
| Oct 31, 2022 | -2.15 Mn |
| Jul 31, 2022 | -2.01 Mn |
| Apr 30, 2022 | -3.10 Mn |
| Jan 31, 2022 | -2.18 Mn |
| Oct 31, 2021 | -1.65 Mn |
| Jul 31, 2021 | -2.90 Mn |